Table 2.
Relationship between the SATB2-AS1 expression and HCC patients’ clinical features
| Clinical parameters | Patients (n) | Expression of SATB2-AS1 | P-value | ||
|---|---|---|---|---|---|
| High-SATB2-AS1 | Low-SATB2-AS1 | ||||
| Total | 84 | 42 | 42 | ||
| Age (years) | < 70 | 34 | 15 | 19 | 0.374 |
| ≥ 70 | 50 | 27 | 23 | ||
| Gender | Male | 45 | 25 | 20 | 0.274 |
| Female | 39 | 17 | 22 | ||
| Tumor size (cm) | < 5 | 24 | 14 | 10 | 0.334 |
| ≥ 5 | 60 | 28 | 32 | ||
| Serum AFP(ng/ml) | < 20 | 33 | 15 | 18 | 0.503 |
| ≥ 20 | 51 | 27 | 24 | ||
| Cirrhosis of the liver | Yes | 58 | 28 | 30 | 0.637 |
| No | 26 | 14 | 12 | ||
| TNM stage | I-II | 34 | 23 | 11 | 0.008* |
| III-IV | 50 | 19 | 31 | ||
| Tumor recurrence | Yes | 59 | 25 | 34 | 0.032* |
| No | 25 | 17 | 8 | ||
*P < 0.05 was statistically significant